Efficacy and Safety of Pharmacotherapeutic Smoking Cessation Aids in Schizophrenia Spectrum Disorders: Subgroup Analysis of EAGLES.
CONCLUSIONS: For smokers with schizophrenia, varenicline led to significantly higher abstinence rates, and NNT was comparable to the control group. A significant proportion of NPSAEs occurred during early abstinence. No treatment significantly increased NPSAE prevalence.
PMID: 33138708 [PubMed - as supplied by publisher]
Source: Psychiatric Services - Category: Psychiatry Tags: Psychiatr Serv Source Type: research
More News: Brain | Bupropion | Chantix | HIV AIDS | Legislation | Neurology | Nicotine | Nicotine Replacement Therapy | Psychiatry | Schizophrenia | Smokers | Study | Wellbutrin